- Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
- The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
- PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
83. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19
Aug 31, 2020 | Clinical Trial
Aug 31, 2020 | Clinical Trial
81. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19
Aug 31, 2020 | Clinical Trial
80. BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies
Aug 27, 2020 | Collaboration
79. Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect SARS-CoV-2 Infection
Aug 27, 2020 | Diagnostics
78. Laurent Pharmaceuticals Receives Approval from FDA to Initiate its COVID-19 Phase 2 Clinical Trial in the United States
Aug 27, 2020 | Regulatory
77. FDC Launches Two Variants of Favipiravir for COVID-19 in India
Aug 27, 2020 | Launch
76. Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program
Aug 26, 2020 | Clinical Trial
75. INTAS Develops COVID-19 Hyperimmune Globulin
Aug 26, 2020 | Regulatory
74. Capricor Therapeutics Report the US FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
Aug 25, 2020 | Regulatory
73. AstraZeneca Initiates P-I Study of AZD7442 Against COVID-19
Aug 25, 2020 | Clinical Trial
72. Bolder BioTechnology Announces Positive Preclinical Data for Use of BBT-032 to Inhibit Growth of the SARS-CoV-2 Virus
Aug 25, 2020 | Clinical Trial
71. Asalyxa Bio Launches with Novel Neutrophil-Targeting Drug Delivery Platform Technology and Lead Candidate, ASX-100 for ARDS and COVID-19 Patients
Aug 25, 2020 | Launch
70. Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19
Aug 25, 2020 | DigiHealth
69. EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics
Aug 25, 2020 | Collaboration
68. Mereo BioPharma Initiates P-Ib/II Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
Aug 25, 2020 | Clinical Trial
67. Altimmune and the University of Alabama at Birmingham Report Potent Respiratory Mucosal T Cell Responses in Preclinical Study of Single-Dose Intranasal COVID-19 Vaccine Candidate, AdCOVID
Aug 25, 2020 | Clinical Trial
66. Partner Therapeutics Initiates Patient Enrollment in US Clinical Trial Evaluating Leukine (rhuGM-CSF, sargramostim) in COVID-19 Patients
Aug 25, 2020 | Clinical Trial
65. First Rapid Corona Antigen Test Approved for Clinical Study in Germany
Aug 25, 2020 | Diagnostics
64. Flexibility, Speed Enabling Actifio to Help in Pursuit of COVID-19 Treatments
Aug 25, 2020 | DigiHealth
63. Kedrion Biopharma and Kamada Continue Their Collaboration to Develop a New Anti-COVID Plasma-Based Treatment
Aug 25, 2020 | Collaboration
62. UNION therapeutics Completes Dosing of Healthy Volunteers with UNI911 (inhaled niclosamide) for COVID-19
Aug 25, 2020 | Clinical Trial
61. Medicure AGGRASTAT Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
Aug 25, 2020 | Clinical Trial
60. Terumo and Cytosorbent Collaborate to Commercialize CytoSorb in Ten US COVID-19 Hotspot States
Aug 25, 2020 | Collaboration
59. Pfizer and BioNTech Plan for Regulatory Review of its COVID-19 Vaccine in October 2020
Aug 21, 2020 | Regulatory
58. BioSymetrics Signs an Agreement with Janssen and Sema4 to Utilize AI for the Prediction of COVID-19
Aug 20, 2020 | Collaboration
57. Sorrento Files IND for STI-1499 (COVI-GUARD) in Patients Hospitalized with COVID-19
Aug 20, 2020 | Regulatory
56. Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains
Aug 20, 2020 | Launch
55. Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases
Aug 20, 2020 | DigiHealth
54. Finding Clues to a Successful Immune Response in the T Cells of Recovered COVID-19 Patients
Aug 21, 2020 | Clinical Trial
53. JanOne to Discuss JAN101 for Treatment of PAD and Potential Applications for COVID-19 Vascular Complications
Aug 21, 2020 | Clinical Trial
52. Co-Diagnostics Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test
Aug 20, 2020 | Diagnostics
51. Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients
Aug 20, 2020 | Clinical Trial
50. LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test
Aug 20, 2020 | Diagnostics
49. Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit
Aug 20, 2020 | Diagnostics
48. Regeneron Collaborates with Roche to Improve the Global Supply of REGN-COV2 Against COVID-19
Aug 19, 2020 | Collaboration
47. Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients
Aug 19, 2020 | Clinical Trial
46. Bio-Techne and Leica Biosystems Accelerates Disease Research with RNAscope COVID-19 Probes and the BOND RX
Aug 19, 2020 | Clinical Trial
45. Ampio Provides Update on COVID-19 Clinical Trial Activities
Aug 19, 2020 | Clinical Trial
44. Harbour BioMed, Utrecht University, Erasmus Medical Center, Viroclinics-DDL and Kiadis Pharma Collaborate to Develop Monoclonal Antibody for COVID-19
Aug 19, 2020 | Collaboration
43. NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial
Aug 18, 2020 | Grant
42. AstraZeneca Collaborates with mAbxience to Produce COVID-19 Vaccine in Latin America
Aug 18, 2020 | Collaboration
41. Vnada’s Interim Analysis from ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID-19 Pneumonia
Aug 18, 2020 | Clinical Trial
40. BOLD-100 Significantly Outperforms Remdesivir Head-to-Head in SARS-CoV-2 (COVID-19) Model
Aug 17, 2020 | Clinical Trial
39. Pharming Announces the Publication of Data from a Compassionate Use Programme of RUCONEST in COVID-19 patients in a Peer-Reviewed Journal
Aug 17, 2020 | Clinical Trial
38. Novavax Collaborates with UK Government to Supply 60M Doses of NVX-CoV2373 to Combat COVID-19
Aug 14, 2020 | Collaboration
37. SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19 Vaccine
Aug 14, 2020 | Collaboration
36. EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine
Aug 14, 2020 | Collaboration
35. AstraZeneca to Initiate Production of its COVID-19 Vaccine Early in 2021
Aug 14, 2020 | Clinical Trial
34. Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19
Aug 13, 2020 | Clinical Trial
33. UNION Therapeutics Enters Option Agreement to Acquire Worldwide Exclusive License for COVID-19 Technologies Developed by TFF Pharmaceuticals
Aug 13, 2020 | Collaboration
32. Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
Aug 13, 2020 | Collaboration
31. Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing
Aug 13, 2020 | Diagnostics
30. Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India
Aug 13, 2020 | Launch
29. Puradigm Announces Successful Tests of its Proactive Air and Surface Purification Technology in Deactivating SARS-CoV-2
Aug 10, 2020 | Diagnostics
28. New Study Proves Asclepius Meditec’s Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea
Aug 10, 2020 | Diagnostics
27. Vela Diagnostics ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA’s Emergency Use Authorization
Aug 07, 2020 | Diagnostics
26. Daiichi Sankyo Selected as Provider for Japanese Government’s Emergent Initiative to Build Production Capacity for COVID-19 Vaccines
Aug 07, 2020 | Collaboration
25. Serum Institute to Produce COVID-19 Vaccines From AstraZeneca, Novavax
Aug 07, 2020 | Collaboration
24. Amarin Supports Study of Vascepa in Reducing Viral Upper Respiratory Infection
Aug 07, 2020 | Clinical Trial
23. Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment Acquires IP From World Leader in Respiratory Disease Medicine
Aug 06, 2020 | Collaboration
22. Moderna Prices its COVID-19 Vaccine at $32-$37 per Dose for Smaller Volume Agreements
Aug 06, 2020 | Collaboration
21. Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B
Aug 06, 2020 | Collaboration
20. Glenmark Introduces FabiFlu (400mg) to Reduce Pill Burden of COVID-19 Treatment
Aug 06, 2020 | Launch
19. NIH Begins Clinical Trial Testing of Remdesivir + Interferon Beta-1a for COVID-19
Aug 06, 2020 | Clinical Trial
18. SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program
Aug 06, 2020 | Grant
17. Pfizer AND BioNTech To Supply BNT162 mRNA- based Vaccine Candidate in Canada
Aug 05, 2020 | Collaboration
16. Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19
Aug 05, 2020 | Regulatory
15. Texas Startup Industrial Genetics Launches Surface and Wastewater Testing for the COVID-19 Virus (SARS-CoV-2)
Aug 05, 2020 | Launch
14. Zydus Cadila Announces Completion of Dosing in Phase I Clinical Trial of ZyCoV-D
Aug 05, 2020 | Clinical Trial
13. Centex Studies-Lake Charles to be the Only Site in SWLA to Run AstraZeneca COVID Vaccine Clinical Trial
Aug 05, 2020 | Clinical Trial
12. Celularity Announces the Activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19
Aug 05, 2020 | Grant
11. Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India
Aug 05, 2020 | Launch
10. BioNTech and Fosun Pharma Initiate Clinical Trial of BNT162b1 Against COVID-19 in China
Aug 05, 2020 | Clinical Trial
9. Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19
Aug 04, 2020 | Collaboration
8. Sanofi and GSK Receive $2.1B from the US Government to Supply 100M Doses of COVID-19 Vaccine
Aug 04, 2020 | Grant
7. Tiziana Life Sciences Expedite Clinical Development Plan for TZLS-501 for COVID-19
Aug 04, 2020 | Clinical Trial
6. Novavax Reports Positive Early Results for Experimental COVID-19 Vaccine NVX-CoV2373
Aug 04, 2020 | Clinical Trial
5. VERU-111 Suppresses Key Cytokines Responsible for Severe Acute Respiratory Distress Syndrome in COVID-19
Aug 04, 2020 | Clinical Trial
4. Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
Aug 04, 2020 | Clinical Trial
3. Innovation Pharmaceuticals and US Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
Aug 04, 2020 | Diagnostic
2. Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19
Aug 03, 2020 | Clinical Trial
1. Rival Drugmakers Launch Joint Trial of Medicines for COVID-19
Aug 03, 2020 | Clinical Trial
Related Post: Insights+: COVID-19 Healthcare News Monthly Updates – September 2020
